schliessen

Filtern

 

Bibliotheken

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer

BACKGROUND: The p53 gene encodes a nuclear phosphoprotein present in low levels in normal human cells. The wild-type form of this protein functions to restrain inappropriate cellular proliferation. Approximately one half of human epithelial ovarian cancers have mutations in the p53 gene and overexpr... Full description

Journal Title: Journal of the National Cancer Institute Sept 15, 1993, Vol.85(18), p.1513(7)
Main Author: Kohler, Matthew F.
Other Authors: Marks, Jeffrey R. , Wiseman, Roger W. , Jacobs, Ian J. , Davidoff, Andrew M. , Clarke - Pearson, Daniel L. , Soper, John T. , Bast, Robert C. , Jr. , Berchuck, Andrew
Format: Electronic Article Electronic Article
Language:
Subjects:
ID: ISSN: 0027-8874
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: gale_hrca14227841
title: Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer
format: Article
creator:
  • Kohler, Matthew F.
  • Marks, Jeffrey R.
  • Wiseman, Roger W.
  • Jacobs, Ian J.
  • Davidoff, Andrew M.
  • Clarke - Pearson, Daniel L.
  • Soper, John T.
  • Bast, Robert C. , Jr.
  • Berchuck, Andrew
subjects:
  • Ovarian Cancer -- Genetic Aspects
  • Tumor Suppressor Genes -- Abnormalities
  • Mutation -- Research
ispartof: Journal of the National Cancer Institute, Sept 15, 1993, Vol.85(18), p.1513(7)
description: BACKGROUND: The p53 gene encodes a nuclear phosphoprotein present in low levels in normal human cells. The wild-type form of this protein functions to restrain inappropriate cellular proliferation. Approximately one half of human epithelial ovarian cancers have mutations in the p53 gene and overexpress the mutant protein product. Deletion of one allele of the p53 gene also frequently occurs in these cancers.PURPOSE: We sought to define the spectrum of mutations in the p53 gene in epithelial ovarian cancer with respect to both the specific codons involved and the type of mutations observed. We also examined the frequency of allelic deletion of the p53 gene in cancers containing p53 gene mutations.METHODS: Tissue samples from the epithelial ovarian cancers of 62 patients were obtained during initial laparotomy. Histologic examination was done to ensure that the experimental samples used in this study contained more than 75% cancer cells. Total RNA was extracted from these samples and separately from matched control noncancerous regions of the surgical specimen or white blood cells. The purified RNAs were reverse transcribed to generate cDNA copies of exons 4-10 of the p53 gene. Two rounds of polymerase chain reaction (PCR) were conducted to produce enough template for DNA sequence analysis of the regions of interest within the p53 gene. Dideoxy sequencing of at least two independent productions of each amplified DNA template was done to confirm the validity of the mutations found. Allelic deletions were identified by PCR and gel electrophoretic techniques to examine three polymorphisms within the p53 gene in cancer-normal DNA pairs.RESULTS: We identified 45 mutations in exons 5-8 of the p53 gene, where mutations frequently have been found in other cancer types. An additional mutation was identified in exon 4. Overall, 72% of the mutations were transitions, 24% transversions, and 4% microdeletions. Allelic deletion of the other p53 allele was seen in 67% of ovarian cancers in which a p53 mutation was present. Germ-line p53 mutations were not found in any patients whose cancers had p53 mutations.CONCLUSIONS AND IMPLICATIONS: Like p53 mutations in other types of human cancers, those in epithelial ovarian cancers are diverse and occur frequently in exons 5-8. The predominance of transition mutations suggests that p53 mutations in ovarian cancer arise because of spontaneous errors in DNA synthesis and repair rather than the direct interaction of carcinogens with
language:
source:
identifier: ISSN: 0027-8874
fulltext: fulltext
issn:
  • 0027-8874
  • 00278874
url: Link


@attributes
ID452332605
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid14227841
sourceidgale_hrca
recordidTN_gale_hrca14227841
sourceformatXML
sourcesystemPC
pqid235568091
galeid14227841
display
typearticle
titleSpectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer
creatorKohler, Matthew F. ; Marks, Jeffrey R. ; Wiseman, Roger W. ; Jacobs, Ian J. ; Davidoff, Andrew M. ; Clarke - Pearson, Daniel L. ; Soper, John T. ; Bast, Robert C. , Jr. ; Berchuck, Andrew
ispartofJournal of the National Cancer Institute, Sept 15, 1993, Vol.85(18), p.1513(7)
identifierISSN: 0027-8874
subjectOvarian Cancer -- Genetic Aspects ; Tumor Suppressor Genes -- Abnormalities ; Mutation -- Research
source
descriptionBACKGROUND: The p53 gene encodes a nuclear phosphoprotein present in low levels in normal human cells. The wild-type form of this protein functions to restrain inappropriate cellular proliferation. Approximately one half of human epithelial ovarian cancers have mutations in the p53 gene and overexpress the mutant protein product. Deletion of one allele of the p53 gene also frequently occurs in these cancers.PURPOSE: We sought to define the spectrum of mutations in the p53 gene in epithelial ovarian cancer with respect to both the specific codons involved and the type of mutations observed. We also examined the frequency of allelic deletion of the p53 gene in cancers containing p53 gene mutations.METHODS: Tissue samples from the epithelial ovarian cancers of 62 patients were obtained during initial laparotomy. Histologic examination was done to ensure that the experimental samples used in this study contained more than 75% cancer cells. Total RNA was extracted from these samples and separately from matched control noncancerous regions of the surgical specimen or white blood cells. The purified RNAs were reverse transcribed to generate cDNA copies of exons 4-10 of the p53 gene. Two rounds of polymerase chain reaction (PCR) were conducted to produce enough template for DNA sequence analysis of the regions of interest within the p53 gene. Dideoxy sequencing of at least two independent productions of each amplified DNA template was done to confirm the validity of the mutations found. Allelic deletions were identified by PCR and gel electrophoretic techniques to examine three polymorphisms within the p53 gene in cancer-normal DNA pairs.RESULTS: We identified 45 mutations in exons 5-8 of the p53 gene, where mutations frequently have been found in other cancer types. An additional mutation was identified in exon 4. Overall, 72% of the mutations were transitions, 24% transversions, and 4% microdeletions. Allelic deletion of the other p53 allele was seen in 67% of ovarian cancers in which a p53 mutation was present. Germ-line p53 mutations were not found in any patients whose cancers had p53 mutations.CONCLUSIONS AND IMPLICATIONS: Like p53 mutations in other types of human cancers, those in epithelial ovarian cancers are diverse and occur frequently in exons 5-8. The predominance of transition mutations suggests that p53 mutations in ovarian cancer arise because of spontaneous errors in DNA synthesis and repair rather than the direct interaction of carcinogens with DNA. These molecular data are consistent with data from epidemiologic studies that have failed to demonstrate a convincing relationship between exposure to environmental carcinogens and the development of ovarian cancer.
version6
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
search
creatorcontrib
0Kohler, Matthew F
1Marks, Jeffrey R
2Wiseman, Roger W
3Jacobs, Ian J
4Davidoff, Andrew M
5Clarke-Pearson, Daniel L
6Soper, John T
7Bast, Robert C., Jr
8Berchuck, Andrew
titleSpectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.
subject
0Ovarian cancer--Genetic aspects
1Tumor suppressor genes--Abnormalities
2Mutation--Research
general
0U.S. National Cancer Institute
1Cengage Learning, Inc.
sourceidgale_hrca
recordidgale_hrca14227841
issn
00027-8874
100278874
rsrctypearticle
creationdate1993
recordtypearticle
addtitleJournal of the National Cancer Institute
searchscopegale_hrca
scopegale_hrca
lsr30VSR-Enriched:[description, doi, pages, pqid, galeid, eissn]
sort
titleSpectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.
authorKohler, Matthew F. ; Marks, Jeffrey R. ; Wiseman, Roger W. ; Jacobs, Ian J. ; Davidoff, Andrew M. ; Clarke - Pearson, Daniel L. ; Soper, John T. ; Bast, Robert C. , Jr. ; Berchuck, Andrew
creationdate19930915
facets
frbrgroupid5092274167655176531
frbrtype5
creationdate1993
topic
0Ovarian Cancer–Genetic Aspects
1Tumor Suppressor Genes–Abnormalities
2Mutation–Research
collectionHealth Reference Center Academic (Gale)
prefilterarticles
rsrctypearticles
creatorcontrib
0Kohler, Matthew F.
1Marks, Jeffrey R.
2Wiseman, Roger W.
3Jacobs, Ian J.
4Davidoff, Andrew M.
5Clarke - Pearson, Daniel L.
6Soper, John T.
7Bast, Robert C. , Jr.
8Berchuck, Andrew
jtitleJournal of the National Cancer Institute
toplevelpeer_reviewed
frbr
t2
k11993
k200278874
k485
k518
k61513
k7journal of the national cancer institute
k8spectrum of mutation frequency of allelic deletion of the p53 gene in ovarian cancer
k9spectrumofmutationanancer
k12spectrumofmutationandfreq
k15matthewfkohler
k16kohlermatthewf
delivery
delcategoryRemote Search Resource
fulltextfulltext
ranking
booster11
booster21
pcg_typeaggregator
addata
au
0Kohler, Matthew F.
1Marks, Jeffrey R.
2Wiseman, Roger W.
3Jacobs, Ian J.
4Davidoff, Andrew M.
5Clarke-Pearson, Daniel L.
6Soper, John T.
7Bast, Robert C., Jr.
8Berchuck, Andrew
atitleSpectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.
jtitleJournal of the National Cancer Institute
risdate19930915
volume85
issue18
spage1513
issn0027-8874
genrearticle
ristypeJOUR
pubU.S. National Cancer Institute
lad01gale_hrca
doi10.1093/jnci/85.18.1513
pages1513-159
eissn14602105
date1993-09-15